Zobrazeno 1 - 10
of 393
pro vyhledávání: '"HG van der Poel"'
Autor:
CN Tillier, AH Boekhout, H Veerman, BM Wollersheim, PAM Groen, HG van der Poel, LV van de Poll-Franse
Purpose/ Background: To examine whether a discrepancy between patient reported outcomes (PROs) and clinician reported outcomes (CROs) impacts the management of urinary incontinence (UI) and erectile dysfunction (ED) after robot assisted radical prost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4982de52714f18b0fdcd0872094663cf
https://doi.org/10.21203/rs.3.rs-1861258/v1
https://doi.org/10.21203/rs.3.rs-1861258/v1
Autor:
Özman O; Urology Department, The Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Urology, Amsterdam, The Netherlands., Veerman H; Urology Department, The Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Urology, Amsterdam, The Netherlands.; Prostate Cancer Network, the Netherlands.; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Hagens MJ; Urology Department, The Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Urology, Amsterdam, The Netherlands.; Prostate Cancer Network, the Netherlands.; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., van Leeuwen PJ; Urology Department, The Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Urology, Amsterdam, The Netherlands.; Prostate Cancer Network, the Netherlands., Vis AN; Urology Department, The Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Urology, Amsterdam, The Netherlands.; Prostate Cancer Network, the Netherlands.; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., van der Poel HG; Urology Department, The Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Urology, Amsterdam, The Netherlands.; Prostate Cancer Network, the Netherlands.; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Publikováno v:
Nuclear medicine communications [Nucl Med Commun] 2025 Jan 01; Vol. 46 (1), pp. 83-88. Date of Electronic Publication: 2024 Dec 10.
Autor:
Ettema RH; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands; Department of Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: r.h.ettema@amsterdamumc.nl., Mellema JJ; Department of Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Oudshoorn FHK; Department of Urology, Spaarne Gasthuis Hospital, Haarlem, The Netherlands., Luining WI; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van der Gaag S; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Lam MGEH; Department of Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The Netherlands., van den Bergh RCN; Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Dec 17. Date of Electronic Publication: 2024 Dec 17.
Autor:
Berrens AC; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. a.c.berrens@amsterdamumc.nl.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands. a.c.berrens@amsterdamumc.nl.; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands. a.c.berrens@amsterdamumc.nl., Buckle T; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van Oosterom MN; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., Slof LJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Wit EMK; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., de Barros HA; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands., Bekers EM; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Leeuwen FWB; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Dec 13. Date of Electronic Publication: 2024 Dec 13.
Autor:
Berrens AC; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands. a.c.berrens@amsterdamumc.nl.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands. a.c.berrens@amsterdamumc.nl.; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands. a.c.berrens@amsterdamumc.nl., Buckle T; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van Oosterom MN; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., Slof LJ; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Wit EMK; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., de Barros HA; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands., Bekers EM; Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Leeuwen FWB; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.
Autor:
Avitan O; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Elst L; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Vreeburg M; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Rafael T; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Jordanova K; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Graafland N; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hendricksen K; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Rhijn BWG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Albersen M; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Brouwer O; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2024 Dec 05; Vol. 71, pp. 63-68. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2025).
Autor:
Vlaming M; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Kiemeney LALM; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.; Department of Urology, Radboud university medical center, Nijmegen, The Netherlands., Schijven G; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., van Melick HHE; Department of Urology, St. Antonius Hospital, Utrecht-Nieuwegein, The Netherlands., Noordzij MA; Department of Urology, Spaarne Gasthuis, Hoofddorp, The Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., van der Poel HG; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Wijburg CJ; Department of Urology, Rijnstate Hospital, Arnhem, The Netherlands., Wijsman BP; Department of Urology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Hoekstra RJ; Department of Urology, Catharina Hospital, Eindhoven, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Bezooijen BPJ; Department of Urology, Meander Medical Center, Amersfoort, The Netherlands., Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands., Busstra MB; Department of Urology, Franciscus Gasthuis, Rotterdam, The Netherlands., van den Berg HP; Department of Internal Medicine, Tergooi Medical Center, Hilversum, The Netherlands., Robbrecht DGJ; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands., Doornweerd BHJ; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands., Bleiker EMA; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., van Oort IM; Department of Urology, Radboud university medical center, Nijmegen, The Netherlands. inge.vanoort@radboudumc.nl.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Dec 05. Date of Electronic Publication: 2024 Dec 05.
Autor:
Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Papa N; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Veerman H; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., de Bie K; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Morton A; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Franklin A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Raveenthiran S; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Yaxley WJ; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Samaratunga H; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Pathology, Aquesta Uropathology, Brisbane, Queensland, Australia., Wong D; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Brown N; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Parkinson R; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Gianduzzo T; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Kua B; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Coughlin GD; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Emmett L; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia., van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Yaxley JW; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; The Wesley Hospital, Brisbane, Queensland, Australia., Vis AN; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.
Publikováno v:
BJU international [BJU Int] 2024 Dec; Vol. 134 Suppl 2, pp. 47-55. Date of Electronic Publication: 2024 Sep 11.
Autor:
Berrens AC; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. a.c.berrens@amsterdamumc.nl.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands. a.c.berrens@amsterdamumc.nl.; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands. a.c.berrens@amsterdamumc.nl., Buckle T; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van Oosterom MN; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., Slof LJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Wit EMK; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., de Barros HA; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands., Bekers EM; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Leeuwen FWB; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Autor:
Pisano G; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, The Netherlands.; Section of Nuclear Medicine, University Department of Radiological Sciences and Haematology, Università Cattolica del Sacro Cuore, Rome, Italy., van Oosterom MN; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Berrens AC; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Slof LJ; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Design and Prototyping, Department of Medical Technology, Leiden University Medical Centre, Leiden, The Netherlands., Rietbergen DDD; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands; and., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centre, Location VUmc, Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Leeuwen FWB; Interventional Molecular Imaging Laboratory, Leiden University Medical Centre, Leiden, The Netherlands; f.w.b.van_leeuwen@lumc.nl.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Nov 01; Vol. 65 (11), pp. 1816-1817. Date of Electronic Publication: 2024 Nov 01.